These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1719277)

  • 1. Postsynaptic alpha 1-blockade with terazosin does not modify insulin sensitivity in nonobese normotensive subjects.
    Ferrari P; Rosman J; Neuner N; Shaw S; Riesen W; Weidmann P
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):106-10. PubMed ID: 1719277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin sensitivity and atrial natriuretic factor during beta-receptor modulation with celiprolol in normal subjects.
    Böhlen LM; de Courten M; Hafezi F; Shaw S; Riesen W; Weidmann P
    J Cardiovasc Pharmacol; 1994 Jun; 23(6):877-83. PubMed ID: 7523778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unaltered insulin sensitivity during calcium channel blockade with amlodipine.
    Ferrari P; Giachino D; Weidmann P; Shaw S; Riesen W; Neuner N; Keller U; Heynen G
    Eur J Clin Pharmacol; 1991; 41(2):109-13. PubMed ID: 1835931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin sensitivity in normotensive subjects during angiotensin converting enzyme inhibition with fosinopril.
    Allemann Y; Baumann S; Jost M; Ferrari P; Shaw S; Riesen W; Weidmann P
    Eur J Clin Pharmacol; 1992; 42(3):275-80. PubMed ID: 1533588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of angiotensin II-receptor blockade with losartan on insulin sensitivity, lipid profile, and endothelin in normotensive offspring of hypertensive parents.
    Lerch M; Teuscher AU; Beissner P; Schneider M; Shaw SG; Weidmann P
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):576-80. PubMed ID: 9554807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive therapy with once-daily administration of terazosin, a new alpha 1-adrenergic-receptor blocker.
    Abraham PA; Halstenson CE; Matzke GR; Napier JL; Keane WF
    Pharmacotherapy; 1985; 5(5):285-9. PubMed ID: 2866492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
    Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
    Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-1-adrenergic blockade and lipoprotein metabolism in essential hypertension.
    Ferrier C; Beretta-Piccoli C; Weidmann P; Mordasini R
    Clin Pharmacol Ther; 1986 Nov; 40(5):525-30. PubMed ID: 2876796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of insulin sensitivity measured by the minimal model method.
    Ferrari P; Alleman Y; Shaw S; Riesen W; Weidmann P
    Diabetologia; 1991 Jul; 34(7):527-30. PubMed ID: 1916059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of terazosin on the lipid profile in patients with symptomatic benign prostatic hyperplasia.
    Akbay E; Bozlu M; Doruk E; Akbay E; Cayan S; Ulusoy E
    Urol Int; 2001; 67(2):156-9. PubMed ID: 11490211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of terazosin on serum lipids.
    Deger G
    Am J Med; 1986 May; 80(5B):82-5. PubMed ID: 2872813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lisinopril is neutral to insulin sensitivity and serum lipoproteins in essential hypertensive patients.
    Thürig C; Böhlen L; Schneider M; de Courten M; Shaw SG; Riesen W; Weidmann P
    Eur J Clin Pharmacol; 1995; 49(1-2):21-6. PubMed ID: 8751016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 1-adrenergic blockade and cardiovascular pressor responses in essential hypertension.
    Beretta-Piccoli C; Ferrier C; Weidmann P
    Hypertension; 1986 May; 8(5):407-14. PubMed ID: 2870984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of alpha-adrenergic and beta-adrenergic receptor blockade on lipid metabolism.
    Ferrara LA; Marotta T; Rubba P; De Simone B; Leccia G; Soro S; Mancini M
    Am J Med; 1986 Feb; 80(2A):104-8. PubMed ID: 2868656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension in rats.
    Keen HL; Brands MW; Alonso-Galicia M; Hall JE
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1192-9. PubMed ID: 8972890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terazosin: an effective once-daily monotherapy for the treatment of hypertension.
    Dauer AD
    Am J Med; 1986 May; 80(5B):29-34. PubMed ID: 2872804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension.
    Deger G
    Am J Med; 1986 May; 80(5B):62-7. PubMed ID: 2872809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pressure and metabolic effects of terazosin in essential hypertension].
    Valle R; Semplicini A; Serena L; Gebbin A; Fontebasso A; Gerardi G; De Toni R; Pessina AC
    Cardiologia; 1994 Jun; 39(6):421-4. PubMed ID: 7923256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance due to chronic salt restriction is corrected by alpha and beta blockade and by L-arginine.
    Ruivo GF; Leandro SM; do Nascimento CA; Catanozi S; Rocha JC; Furukawa LN; Dolnikoff MS; Quintão EC; Heimann JC
    Physiol Behav; 2006 Jul; 88(4-5):364-70. PubMed ID: 16737723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.